Rachael leads research projects on pharmacy and diagnostic topics. At Advisory Board, she’s explored innovative genetic tests and their impact on oncology care. She’s also researched and broken down key affordability questions for new treatment modalities, including gene therapies and weight loss medications.

Prior to joining Advisory Board, Rachael worked as a consultant at Real Chemistry where she helped life sciences companies develop proactive value-based care strategies for their products. Rachael received a Master of Science in Public Health degree from Johns Hopkins Bloomberg School of Public Health and a bachelor’s degree in political science and biochemistry from Carleton College.